T. Rowe Price Associates’s Aurinia Pharmaceuticals AUPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $497K | Sell |
58,656
-382
| -0.6% | -$3.24K | ﹤0.01% | 2301 |
|
|
2025
Q1 | $475K | Buy |
59,038
+6,940
| +13% | +$55.8K | ﹤0.01% | 2263 |
|
|
2024
Q4 | $468K | Buy |
52,098
+8,350
| +19% | +$75K | ﹤0.01% | 2302 |
|
|
2024
Q3 | $321K | Sell |
43,748
-1,959
| -4% | -$14.4K | ﹤0.01% | 2446 |
|
|
2024
Q2 | $261K | Buy |
45,707
+6,755
| +17% | +$38.6K | ﹤0.01% | 2488 |
|
|
2024
Q1 | $196K | Buy |
38,952
+5,079
| +15% | +$25.6K | ﹤0.01% | 2630 |
|
|
2023
Q4 | $305K | Buy |
33,873
+3,494
| +12% | +$31.5K | ﹤0.01% | 2367 |
|
|
2023
Q3 | $237K | Buy |
30,379
+2,968
| +11% | +$23.2K | ﹤0.01% | 2434 |
|
|
2023
Q2 | $266K | Buy |
27,411
+1,484
| +6% | +$14.4K | ﹤0.01% | 2418 |
|
|
2023
Q1 | $285K | Buy |
25,927
+2,906
| +13% | +$31.9K | ﹤0.01% | 2370 |
|
|
2022
Q4 | $99K | Buy |
23,021
+1,563
| +7% | +$6.72K | ﹤0.01% | 2719 |
|
|
2022
Q3 | $162K | Buy |
21,458
+8,659
| +68% | +$65.4K | ﹤0.01% | 2606 |
|
|
2022
Q2 | $129K | Buy |
+12,799
| New | +$129K | ﹤0.01% | 2699 |
|
|
2017
Q2 | – | Sell |
-751,300
| Closed | -$5.52M | – | 2558 |
|
|
2017
Q1 | $5.52M | Buy |
+751,300
| New | +$5.52M | ﹤0.01% | 1416 |
|